Tuesday, December 1, 2020

Meiogenix and Lesaffre collaborate to improve industrial yeast strains’ performance

Meiogenix and Lesaffre have entered into a collaboration agreement to develop improved industrial yeast strains using Meiogenix’s recombination technologies.

The PhoeniX technology developed by Meiogenix controls the process of natural meiotic recombination and generates efficiently non–GM recombined yeast cells particularly for industrial strains where meiosis is impeded.

Meiogenix is a French biotech company that develops technologies to increase the genetic diversity of organisms by modulating meiosis and targeting recombination. Under the collaboration agreement Meiogenix will apply its non-GM technology to discover novel yeast strains with improved industrial properties that will be then industrialized by Lesaffre, a global key player in yeasts and fermentation.

“We are delighted of this collaboration with Lesaffre, a worldwide key player in the industrial yeast field,” said Giacomo Bastianelli, Co-founder & CEO of Meiogenix. “In the last few years we have carried out several R&D projects in yeast and we are glad to put into play the expertise and technologies we have developed. We believe that PhoeniX, a proprietary non-GM technology, can have a major impact in the yeast industry, especially for food applications where mainstream genetic engineering technologies are not yet an accepted option.”

The global market value for industrial yeast is projected to grow at a CAGR of 8.8% and expected to reach $3.6B by 2018. The recent advances in genetic engineering techniques (e.g. CRISPR/CAS9, synthetic biology) can have an unprecedented impact in the development of novel yeast strains but severe concerns about genetically modified organisms used in the food and beverage industry are still a major hurdle for any development and commercialization. Therefore, research efforts will aim at developing new screening methods and technologies for the isolation of natural recombinants with the desired properties.

“Innovation has always been at the heart of Lesaffre’s development. Research and Development is one of Lesaffre’s key drivers for success. Being the brainchild of Dr. Alain Nicolas, a scientist at the Institut Curie, Meiogenix’s innovative technology represents for us an opportunity to generate diversity in yeast. As an alternative to mutagenesis, this technique can improve yeasts and be applied in many fields from baking yeast to biofuels” said Didier Colavizza, R&D Biotech Center Director at Lesaffre.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemic having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £31.50 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.
















Latest news

Plans for ‘better, fairer’ farming system published

The government has this week set out plans to deliver a “better, fairer farming system” in England. According to government, the new plans will “transform...

Danish Crown to future-proof production

Danish Crown, Europe’s largest pork producer, will increase its investment budget by 25%, investing 2 billion DKK in automation as it looks to future-proof...

Labfacility to celebrate 50th anniversary in 2021

Next year, Labfacility, the UK’s leading manufacturer of temperature sensors, thermocouple connectors and associated temperature instrumentation and stockists of thermocouple cables, celebrates its 50th...

RMGroup offers best-in-class service and support to customers throughout the UK

Leading robotics and automation specialists, RMGroup, prides itself in offering its customers the best service and support provision throughout the UK. Consisting of a network...

DSM launches enzyme for lactose-free, sugar-reduced dairy

Royal DSM has launched a new enzyme to produce high-quality and clean-tasting lactose-free and sugar-reduced dairy products. Joining the company’s Maxilact lactose portfolio, Maxilact Super...

Fourth production site for Troy Foods

Troy Foods, a producer of vegetable, salad and mayonnaise, has expanded its operations with the completion of a fourth site. Supported by a £500,000 investment...

Related news

Plans for ‘better, fairer’ farming system published

The government has this week set out plans to deliver a “better, fairer farming system” in England. According to government, the new plans will “transform...

Danish Crown to future-proof production

Danish Crown, Europe’s largest pork producer, will increase its investment budget by 25%, investing 2 billion DKK in automation as it looks to future-proof...

Labfacility to celebrate 50th anniversary in 2021

Next year, Labfacility, the UK’s leading manufacturer of temperature sensors, thermocouple connectors and associated temperature instrumentation and stockists of thermocouple cables, celebrates its 50th...

RMGroup offers best-in-class service and support to customers throughout the UK

Leading robotics and automation specialists, RMGroup, prides itself in offering its customers the best service and support provision throughout the UK. Consisting of a network...

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close